Hap Trading, LLC Siga Technologies Inc Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$7.29 - $10.14 $439,587 - $611,442	-60,300 Reduced 83.4%	12,000 $2,000
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $612,222 - $1.6 Million	61,100 Added 545.54%	72,300 $188,000
Q2 2022 Aug 12, 2022	BUY	$6.5 - $13.68 $72,800 - $153,216	11,200 New	11,200 $24,000
Q1 2022 May 12, 2022	SELL	$5.96 - $7.61 $124,564 - $159,049	-20,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.96 - $9.26 $145,464 - $193,534	20,900 New	20,900 $7,000
Q3 2021 Nov 10, 2021	SELL	$5.71 - $7.39 $57,100 - $73,900	-10,000 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$6.1 - $7.58 $61,000 - $75,800	10,000 New	10,000 $2,000

185

35.8M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $427M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.